JournalsHub
.online
Find My Journal
MH

Mazen Hanna

Cleveland Clinic US

ORCID 0000-0002-7251-3003
288
Publications
12,306
Citations
45
H-Index
101
i10-Index
7.04
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex + Semantic Scholar. OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Most Cited Works

Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy OA
Matthew J. Maurer, Jeffrey H. Schwartz, Balarama Gundapaneni, Perry Elliott, Giampaolo Merlini +17 more
New England Journal of Medicine 2018
2,612
Transthyretin Amyloid Cardiomyopathy OA
Frederick L. Ruberg, Martha Grogan, Mazen Hanna, Jeffery W. Kelly, Mathew S. Maurer
Journal of the American College of Cardiology 2019
1,008
Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis OA
Dermot Phelan, Patrick Collier, Paaladinesh Thavendiranathan, Zoran Popović, Mazen Hanna +3 more
Heart 2012
937
Genotype and Phenotype of Transthyretin Cardiac Amyloidosis OA
Mathew S. Maurer, Mazen Hanna, Martha Grogan, Angela Dispenzieri, Ronald Witteles +20 more
Journal of the American College of Cardiology 2016
520
ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2—evidence base and standardized methods of imaging OA
Sharmila Dorbala, Yukio Ando, Sabahat Bokhari, Angela Dispenzieri, Rodney H. Falk +21 more
Journal of Nuclear Cardiology 2019
460

Publications

287 total

Amyloid-specific medication in transthyretin amyloid cardiomyopathy: a systematic review and meta-analysis of cardiovascular outcome trials.

M. Autherith, L. Hauptmann, S. Koschatko, C. Jantsch, C. Kronberger - Journal of Cardiac Failure, 2025
Cited by 0 Semantic Scholar

Acoramidis-Mediated Improvement in NT-proBNP at Month 30 Compared With Placebo in Patients With ATTR-CM: Results From the ATTRibute-CM Study

N. Sarswat, Ahmad Masri, Kunal Bhatt, Michele Emdin, Emer Joyce - Journal of Nuclear Cardiology, 2025
Cited by 0 Semantic Scholar

ACORAMIDIS IMPROVES CLINICAL OUTCOMES IN PATIENTS WITH TRANSTHYRETIN AMYLOID CARDIOMYOPATHY: A POST HOC RECURRENT EVENT ANALYSIS OF ATTRIBUTE-CM STUDY

D. Judge, K. Alexander, Francesco Cappelli, M. Fontana, Pablo Garcia-Pavia - Journal of Cardiac Failure, 2025
Cited by 1 Semantic Scholar

A Multicenter Study of Contemporary Long-Term Tafamidis Outcomes in Transthyretin Amyloid Cardiomyopathy

Ahmad Masri, Priyanka T Bhattacharya, Brent Medoff, Ain Ejaz, Miriam Elman - JACC CardioOncology, 2025
Cited by 16 Semantic Scholar

Efficacy of Acoramidis on All-Cause Mortality and Cardiovascular Hospitalization in Transthyretin Amyloid Cardiomyopathy. OA

D. Judge, K. Alexander, Francesco Cappelli, M. Fontana, P. García-Pavía - Journal of the American College of Cardiology, 2025
Cited by 29 Semantic Scholar

Efficacy and Safety of Acoramidis in Transthyretin Amyloid Cardiomyopathy PDF

Julian D. Gillmore, Daniel P. Judge, Francesco Cappelli, Marianna Fontana, Pablo García‐Pavía et al. - New England Journal of Medicine, 2024
Cited by 398 OpenAlex

Primary Results From APOLLO-B Open-label Extension Study Of Patisiran In Patients With Transthyretin Cardiac Amyloidosis

M. Maurer, John L. Berk, M. Hanna, J. Gillmore, P. Schwartzmann - Journal of Cardiac Failure, 2024
Cited by 4 Semantic Scholar

Impact Of Patisiran On Health Status And Quality Of Life In Patients With Transthyretin Cardiac Amyloidosis

Zubair Shah, L. Obici, P. Kale, S. Mitter, P. Eldhagen - Journal of Cardiac Failure, 2024
Cited by 1 Semantic Scholar

Patisiran treatment for ATTR cardiac amyloidosis: 18-month results of the phase 3 APOLLO-B study

M. Fontana, J. L Berk, M. Hanna, J. D Gillmore, V. Pedro-Schwartzmann - Archives of Cardiovascular Diseases, 2024
Cited by 0 Semantic Scholar

Evaluation of disease progression in patients with ATTR amyloidosis with cardiomyopathy following treatment with patisiran: Post-hoc analysis of the APOLLO-B study

T. Damy, Z. Shah, B. Drachman, V. Pedro-Schwartzmann, C. Tinoco Mesquita - Archives of Cardiovascular Diseases, 2024
Cited by 0 Semantic Scholar

Research Topics

Amyloidosis: Diagnosis, Treatment, Outcomes (220) Parathyroid Disorders and Treatments (106) Cardiovascular Function and Risk Factors (31) Peptidase Inhibition and Analysis (30) Eosinophilic Disorders and Syndromes (27)

Frequent Co-Authors

MA
Matthew J. Maurer
6 joint publications
MA
Martha Grogan
6 joint publications
SA
Sanjiv J. Shah
6 joint publications
GI
Giampaolo Merlini
5 joint publications
AR
Arnt V. Kristen
5 joint publications
RO
Ronald Witteles
5 joint publications

Affiliations

Twitter (United States)
US 2020 - 2020
Queen's University Belfast
GB 2021 - 2020
Summa Health System
US 2021 - 2021
Cleveland Clinic
US 2026 - 2008
Johns Hopkins University
US 2024 - 2024

External Profiles

OpenAlex Profile Semantic Scholar Profile ORCID Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now